Sertraline maintenance treatment reduced relapse and dropouts in posttraumatic stress disorder

Bisson, Jonathan I.
September 2002
ACP Journal Club;Sep/Oct2002, Vol. 137 Issue 2, p69
Academic Journal
Presents a study that investigated the efficacy of sertraline in preventing relapse of postraumatic stress disorder. Comparison of outcomes in sertraline versus placebo for sertraline responders with posttraumatic stress disorder; Information on study design and main outcome measures; Implications for sertraline maintenance.


Related Articles

  • No better than placebo?  // Art of Healing;Mar-May2012, Vol. 1 Issue 38, p16 

    The article focuses on a study which revealed that antipsychotic drugs used to treat severe post-traumatic stress symptoms among veterans, including Risperdal, Geodon and Abilify, are no more effective than placebos.

  • Sertraline Gets OK As PTSD Remedy. Cerrato, Paul L. // RN;Feb2000, Vol. 63 Issue 2, p90 

    Announces the availability of sertraline for use by patients in the United States who are suffering from post-traumatic stress disorder.

  • sertraline.  // Taber's Cyclopedic Medical Dictionary;2005, p1979 

    A definition of the term "sertraline" is presented. It refers to a serotonin reuptake inhibitor and antidepressant, taken orally to control depression, panic, obsessive compulsive disorder, and posttraumatic stress disorder.

  • Acupuncture for the Treatment of PTSD. Ritchie, Elspeth Cameron // Psychiatric Annals;May2013, Vol. 43 Issue 5, p235 

    The author asserts that many have dismissed anecdotal comments about the effects of acupuncture as only a placebo effect. She says that the mechanism of action for acupuncture to treat post traumatic stress disorder (PTSD) is not yet totally clear. She observes that veterans who experienced...

  • A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder. Feijó Mello, Marcelo; Sau Ling Yeh, Mary; Barbosa Neto, Jair; Lorens Braga, Luciana; Fiks, Jose Paulo; Mendes, Daniela Deise; Moriyama, Tais S.; Marques Valente, Nina Leão; Pupo Costa, Mariana Caddrobi; Mattos, Patricia; Affonseca Bressan, Rodrigo; Baxter Andreoli, Sergio; Mari, Jair Jesus // BMC Psychiatry;2009, Vol. 9, Special section p1 

    Background: Topiramate might be effective in the treatment of posttraumatic stress disorder (PTSD) because of its antikindling effect and its action in both inhibitory and excitatory neurotransmitters. Open-label studies and few controlled trials have suggested that this anticonvulsant may have...

  • Vipassana Meditation: Systematic Review of Current Evidence. Chiesa, Alberto // Journal of Alternative & Complementary Medicine;Jan2010, Vol. 16 Issue 1, p37 

    Objectives: Vipassana meditation (VM) is one of the most ancient and diffused types of meditative practices belonging to the pole of mindfulness. Despite the growing interest toward the neurobiological and clinical correlates of many meditative practices, no review has specifically focused on...

  • Trauma Reactivation Plus Propranolol Is Associated With Durably Low Physiological Responding During Subsequent Script-Driven Traumatic Imagery. Brunet, Alain; Thomas, Émilie; Saumier, Daniel; Ashbaugh, Andrea R.; Azzoug, Abdelmadjid; Pitman, Roger K.; Orr, Scott P.; Tremblay, Jacques // Canadian Journal of Psychiatry;Apr2014, Vol. 59 Issue 4, p228 

    Objective: In a previous, double-blind, placebo-controlled study, patients with posttraumatic stress disorder (PTSD) showed lower physiological response during script-driven traumatic imagery 1 week after receiving a single dose of propranolol given after the retrieval of a traumatic memory. We...

  • Sertraline for post-traumatic stress disorder.  // WHO Drug Information;1999, Vol. 13 Issue 4, p238 

    Reports that the Food and Drug Administration has approved sertraline as the first drug treatment for post-traumatic stress disorders in the U.S.

  • Drug Companies Ignore Hippocrates' Primum Nil Nocere, First, Do No Harm.  // Health & Stress;Feb2013, Vol. 25 Issue 2, p22 

    The article discusses the influence and control of drug companies over regulatory authorities, medical journals and the media. It mentions their acquisition of approval for their products by support from outstanding authorities on their payroll. It notes the drugs Zoloft and Paxil for treating...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics